Esperion Therapeutics

Cytokinetics Inc

Verve Therapeutics

Heartbeam, Inc.

Cardio Diagnostics Holdings Inc.

HeartSciences Inc.

Heartflow, Inc.

Amarin Corporation

Dark pool: 37.0% of volume (WoW: +209.7%)

UBS ATS

SIGMA X2

INSTINCT X

LEVEL ATS

Dilution score: 36/100 (MEDIUM), 36.8 months cash

13F fund flow: accumulation, 24 institutional managers

Polen Capital

Schonfeld

ExodusPoint

Hudson Bay

Acadian

Pentwater

Balyasny

Point72

Brevan Howard

Wellington

656 PubMed publications found for Esperion

Ironing Out the Details: Advancing Diagnosis and Treatment of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction - A Narrative Review.

Low-density lipoprotein cholesterol management and goal attainment at 1 year in patients with diabetes, pre-diabetes and normoglycaemia: results from the European, prospective, observational SANTORINI study.

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

A Contemporary Perspective on Acute Decompensated Heart Failure Classification: A State-of-the-art Review from an International Expert Group.

Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid.

Short interest: 6.82% of float, squeeze risk: LOW

SW convergence: 36/100 (Bearish Convergence), 1 bullish / 1 bearish signals

<article class="bts-verified-summary" data-ticker="ESPR">
<p>Esperion Therapeutics (ESPR) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">ClinicalTrials.gov (2026-04-11) <a href="https://clinicaltrials.gov/search?term=AREA%5BLeadSponsorName%5D+%22Esperion+Therapeutics%22&amp;aggFilters=status%3Arec%2Cact" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

ClinicalTrials.gov

Esperion Therapeutics (ESPR) — BioTechSigns Verified Summary

Esperion Therapeutics (ESPR) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[1].

Sources:
[1] ClinicalTrials.gov. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://clinicaltrials.gov/search?term=AREA%5BLeadSponsorName%5D+%22Esperion+Therapeutics%22&aggFilters=status%3Arec%2Cact

Bempedoic acid pregnancy surveillance program